Quality-adjusted life-years as decisionmaker tools to address limitations inherent in number-needed-to-treat/harm values.
Raisch
Dennis W
DW
Nawarskas
James J
JJ
D003362:Cost-Benefit Analysis; D003657:Decision Making; D017850:Economics, Pharmaceutical / Q000706:statistics & numerical data*; D006801:Humans; D009203:Myocardial Infarction / Q000188:drug therapy; D019039:Platelet Glycoprotein GPIIb-IIIa Complex / Q000037:antagonists & inhibitors; D019057:Quality-Adjusted Life Years; D012107:Research Design; D018570:Risk Assessment; D016896:Treatment Outcome
D019039:Platelet Glycoprotein GPIIb-IIIa Complex